Estimates based on drug properties and standard treatment parameters.
167.6 mL/min
Highly Dialyzable
Significant removal expected. Half-life: 2 hrs (linsidomine). Consider post-dialysis supplementation. Short half-life suggests rapid endogenous clearance may minimize impact of HD.
Data Used:
✅
protein_binding, molar_mass, mw_factor, half_life
⚠️ Missing:
vd
Free fraction:
0.97
Mw factor:
1
Vd factor:
0.8
Hl factor:
0.8
Half life:
2 hrs (linsidomine)
Half life category:
Ultra-short (< 1h)
4.8 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 2 hrs (linsidomine).
Data Used:
✅
protein_binding, molar_mass, half_life
Free fraction:
0.97
Half life:
2 hrs (linsidomine)
Half life category:
Ultra-short (< 1h)
Unable to Assess
Insufficient data for TPE risk assessment. Protein binding and Vd required.
Data Used:
✅
protein_binding, half_life
⚠️ Missing:
vd
Half life:
2 hrs (linsidomine)
Half life category:
Ultra-short (< 1h)
Cannot Assess
Vd data required for hemoadsorption effectiveness assessment.
Data Used:
✅
half_life
⚠️ Missing:
vd
Half life:
2 hrs (linsidomine)
Half life category:
Ultra-short (< 1h)
